GILEAD SCIENCES, INC. Stockholders Equity

• GILEAD SCIENCES, INC. showed an increase of +17.4% in Stockholders Equity from 2024 to 2025.
• This data is from GILEAD SCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2009: $5.19 billion | Q3 2009: $5.65 billion | Q1 2010: $7.34 billion | Q2 2010: $6.56 billion | Q3 2010: $5.71 billion | Q1 2011: $5.95 billion | Q2 2011: $6.05 billion | Q3 2011: $6.12 billion | Q1 2012: $7.31 billion | Q2 2012: $8.00 billion | Q3 2012: $8.60 billion | Q1 2013: $10.15 billion | Q2 2013: $11.09 billion | Q3 2013: $10.88 billion | Q1 2014: $13.39 billion | Q2 2014: $16.09 billion | Q3 2014: $13.57 billion | Q1 2015: $17.18 billion | Q2 2015: $16.29 billion | Q3 2015: $17.41 billion | Q1 2016: $13.40 billion | Q2 2016: $15.54 billion | Q3 2016: $16.87 billion | Q1 2017: $20.44 billion | Q2 2017: $22.68 billion | Q3 2017: $24.85 billion | Q1 2018: $20.59 billion | Q2 2018: $21.67 billion | Q3 2018: $22.86 billion | Q1 2019: $21.95 billion | Q2 2019: $22.62 billion | Q3 2019: $20.60 billion | Q1 2020: $22.07 billion | Q2 2020: $18.03 billion | Q3 2020: $17.45 billion | Q1 2021: $18.95 billion | Q2 2021: $19.70 billion | Q3 2021: $21.47 billion | Q1 2022: $19.93 billion | Q2 2022: $20.24 billion | Q3 2022: $21.08 billion | Q1 2023: $21.00 billion | Q2 2023: $21.16 billion | Q3 2023: $22.31 billion | Q1 2024: $17.54 billion | Q2 2024: $18.28 billion | Q3 2024: $18.48 billion | Q1 2025: $19.16 billion | Q2 2025: $19.67 billion | Q3 2025: $21.54 billion.
• Over the full 18 years of available data (2008 to 2025), GILEAD SCIENCES, INC.'s Stockholders Equity has grown by 431.4%.
• Historical annual values: Fiscal year 2025: $22.70 billion | Fiscal year 2024: $19.33 billion | Fiscal year 2023: $22.83 billion | Fiscal year 2022: $21.24 billion | Fiscal year 2021: $21.07 billion | Fiscal year 2020: $18.20 billion | Fiscal year 2019: $22.53 billion | Fiscal year 2018: $21.39 billion | Fiscal year 2017: $20.44 billion | Fiscal year 2016: $18.89 billion | Fiscal year 2015: $18.53 billion | Fiscal year 2014: $15.43 billion | Fiscal year 2013: $11.37 billion | Fiscal year 2012: $9.30 billion | Fiscal year 2011: $6.74 billion | Fiscal year 2010: $5.86 billion | Fiscal year 2009: $6.37 billion | Fiscal year 2008: $4.27 billion.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026